Form 4: SEC Form 4: Pesicka Reports Stock Transaction
Statement of Changes in Beneficial Ownership
Edward A. Pesicka, President & CEO of ACCENDRA HEALTH INC/VA/, reported a transaction involving common stock on May 15, 2026.
Summary
- Edward A. Pesicka, who holds the positions of Director and President & CEO at ACCENDRA HEALTH INC/VA/, reported a transaction on May 15, 2026.
- The transaction involved the surrender of 17,692 shares of common stock to the issuer to satisfy tax withholding obligations.
- These shares were related to the vesting of restricted stock previously granted to Mr. Pesicka.
- Following this transaction, Mr. Pesicka beneficially owns 1,072,785 shares of common stock directly.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard procedural transaction related to executive compensation rather than a significant strategic event or performance indicator.
Positives
- The transaction indicates that restricted stock granted to the CEO has vested, suggesting a positive progression in compensation and potential alignment of interests.
- Mr. Pesicka continues to hold a significant direct beneficial ownership of 1,072,785 shares, demonstrating a substantial personal investment in the company.
Negatives
- The surrender of shares for tax withholding represents a reduction in the CEO's direct shareholding, albeit a standard practice for vested equity compensation.
Future Outlook
No specific forward-looking statements or guidance were provided in this filing.
Industry Context
StockSavvy.ai notes that Form 4 filings are routine disclosures for corporate insiders and are essential for transparency regarding changes in beneficial ownership. This specific filing details a common event related to equity compensation vesting and tax obligations.
Stakeholder Impact
- Shareholders: The filing provides transparency on insider stock transactions, reinforcing governance standards. The continued substantial ownership by the CEO may be viewed positively.
- Employees: The vesting of restricted stock for the CEO indicates a successful performance period or tenure milestone, which can indirectly reflect on company performance.
- Management: The transaction is a standard part of executive compensation and tax planning.
Key Dates
| Date | Description |
|---|---|
| 05/15/2026 | Transaction Date for surrender of shares |
| 05/19/2026 | Date of signature on the filing |
Keywords
SEC Form 4, Insider Transaction, Stock Vesting, Tax Withholding, Beneficial Ownership, ACCENDRA HEALTH INC/VA/, Edward A. Pesicka, Common Stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.